295 related articles for article (PubMed ID: 18282)
1. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma.
Pitman SW; Frei E
Cancer Treat Rep; 1977 Jul; 61(4):695-701. PubMed ID: 18282
[TBL] [Abstract][Full Text] [Related]
2. [High dose methotrexate with leucovorin rescue in the treatment of malignant lymphoma].
Sampi K; Hattori M
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1068-73. PubMed ID: 6985194
[TBL] [Abstract][Full Text] [Related]
3. High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study.
Parker LM; Griffiths CT; Yankee RA; Knapp RC; Canellos GP
Cancer Treat Rep; 1979 Feb; 63(2):275-9. PubMed ID: 312692
[TBL] [Abstract][Full Text] [Related]
4. [High dose of methotrexate-leucovorin treatment in advanced non-Hodgkin's lymphoma].
Kawarabayashi K; Yoshikawa T; Sannomiya Y; Hashimoto K; Araki J; Park K; Tatumi Y; Kamitani T; Im T; Tatumi N
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2493-9. PubMed ID: 6606395
[TBL] [Abstract][Full Text] [Related]
5. [Effects of infusion duration of high-dose methotrexate on cerebrospinal fluid drug levels in lymphoma patients].
Lin XB; Zhou NN; Li S; Cai QQ; Xia ZJ; Liao H; Gao Y; Huang HQ
Ai Zheng; 2008 Oct; 27(10):1100-5. PubMed ID: 18851792
[TBL] [Abstract][Full Text] [Related]
6. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
[TBL] [Abstract][Full Text] [Related]
8. High-dose methotrexate with citrovorum factor rescue for the treatment of central nervous system tumors in children.
Rosen G; Ghavimi F; Nirenberg A; Mosende C; Mehta BM
Cancer Treat Rep; 1977 Jul; 61(4):681-90. PubMed ID: 301781
[TBL] [Abstract][Full Text] [Related]
9. Combinations of methotrexate (COP or CHOP) in the treatment of previously untreated and treated lymphomas.
Gomez GA; Stutzman L; Moayeri H; Shimaoka K; Plager J; Han T; Naeher C; Henderson E
Cancer Treat Rep; 1982 Jan; 66(1):43-7. PubMed ID: 6975659
[TBL] [Abstract][Full Text] [Related]
10. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
[TBL] [Abstract][Full Text] [Related]
11. [Studies on high-dose methotrexate with citrovorum factor rescue therapy in children: analysis of bone marrow cell kinetics by flow cytometry].
Tsurusawa M; Sasaki K; Matsuoka H; Katano N; Fujimoto T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1827-32. PubMed ID: 3876075
[TBL] [Abstract][Full Text] [Related]
12. [Effects of a massive dosage of methotrexate and leucovorin rescue therapy on acute leukemia and malignant lymphoma].
Gan To Kagaku Ryoho; 1982 Mar; 9(3):421-32. PubMed ID: 6764106
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine.
Abelson HT; Fosburg MT; Beardsley GP; Goorin AM; Gorka C; Link M; Link D
J Clin Oncol; 1983 Mar; 1(3):208-16. PubMed ID: 6607976
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced?
Niemann A; Mühlisch J; Frühwald MC; Gerss J; Hempel G; Boos J
Ther Drug Monit; 2010 Aug; 32(4):467-75. PubMed ID: 20571463
[TBL] [Abstract][Full Text] [Related]
15. High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity.
Frei E; Blum RH; Pitman SW; Kirkwood JM; Henderson IC; Skarin AT; Mayer RJ; Bast RC; Garnick MB; Parker LM; Canellos GP
Am J Med; 1980 Mar; 68(3):370-6. PubMed ID: 6965819
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-leucovorin factor rescue regimens in diffuse large cell lymphoma.
Skarin AT; Canellos GP
NCI Monogr; 1987; (5):71-6. PubMed ID: 3501548
[TBL] [Abstract][Full Text] [Related]
17. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity.
Stoller RG; Hande KR; Jacobs SA; Rosenberg SA; Chabner BA
N Engl J Med; 1977 Sep; 297(12):630-4. PubMed ID: 302412
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of citrovorum factor and carboxypeptidase G1 on cerebrospinal fluid-methotrexate pharmacokinetics.
Abelson HT; Ensminger W; Rosowsky A; Uren J
Cancer Treat Rep; 1978 Oct; 62(10):1549-52. PubMed ID: 309355
[TBL] [Abstract][Full Text] [Related]
19. Antineoplastic agents: high-dose methotrexate and citrovorum factor rescue.
Sadée W
Ther Drug Monit; 1980; 2(2):177-85. PubMed ID: 6762711
[TBL] [Abstract][Full Text] [Related]
20. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]